30
Participants
Start Date
February 15, 2017
Primary Completion Date
August 31, 2018
Study Completion Date
August 15, 2018
Ultrasept LAA Closure System
The Ultrasept Left Atrial Appendage Closure System Device is a percutaneous transcatheter device intended to prevent thrombus embolization from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation.
RECRUITING
Quebec Heart & Lung Institute Laval University, Québec
Lead Sponsor
Cardia Inc.
INDUSTRY